𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families

✍ Scribed by Peelen, T.


Book ID
111724075
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
145 KB
Volume
82
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


BRCA2 germline mutations in Cypriot pati
✍ Andreas Hadjisavvas; Elpida Charalambous; Adamos Adamou; Christina G. Christodou 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Germline mutations in the BRCA2 gene have been shown to be associated with familial female and male breast cancer. Mutations occur throughout the entire coding region of the gene, and there is considerable ethnic and geographical diversity in the deleterious mutations detected in different populatio

BRCA2 germline mutations in Japanese bre
✍ Rie Inoue; Toshikazu Ushijima; Takashi Fukutomi; Atsuo Fukami; Haruhiko Sugimura 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB 👁 2 views

Germline mutations of BRCA2 were examined in 20 Japanese breast cancer families without BRCA1 mutations, including one demonstrating cancer development in a male. Three different mutations, resulting in truncation of the BRCA2 protein, were detected in 3 different families. They were 9474insA (exon

Germline mutations of BRCA1 and BRCA2 in
✍ Hio Chung Kang; Il-Jin Kim; Jae-Hyun Park; Hyuk-Jun Kwon; Yong-Jin Won; Seung Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2

BRCA1 and BRCA2 mutation analysis in bre
✍ Magdalena Perkowska; Izabela BroŻek; Barbara Wysocka; Karin Haraldsson; Therese 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for germline mutations in BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185), using a combination of protein truncation test, denaturing high-performance liquid chromatography and direct sequencing. Sixteen (27%)